A review on the selective apoptotic effect of nonthermal atmospheric-pressure plasma on cancer cells

Plasma Medicine

Volumn 4, Issue 1-4, 2014, Pages 193-209

  Song, Kiwon ^a   Li, Gen ^a   Ma, Yonghao ^a  

^a Yonsei University   (South Korea)

Author keywords

Anticancer therapy; Apoptosis; Cancer cells; Nonthermal atmospheric pressure plasma; p53

Indexed keywords

ATMOSPHERIC PRESSURE; CELL DEATH; CHARGED PARTICLES; DISEASES; IONIZATION OF GASES; MEDICAL APPLICATIONS; TEMPERATURE;

ANTI-CANCER THERAPIES; BIOMEDICAL APPLICATIONS; CANCER CELLS; DNA DOUBLE STRAND BREAKS; NONTHERMAL ATMOSPHERIC PRESSURE PLASMAS; PARTIALLY-IONIZED GAS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

CELL SIGNALING;

MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; ATMOSPHERIC PRESSURE; BIOLOGICAL ACTIVITY; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CANCER THERAPY; CELL CYCLE CHECKPOINT; CELL CYCLE REGULATION; CELL DEATH; CLINICAL EVALUATION; DNA DAMAGE CHECKPOINT; DOUBLE STRANDED DNA BREAK; GENETIC ANALYSIS; GENOMIC INSTABILITY; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; NONTHERMAL ATMOSPHERIC PRESSURE PLASMA; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THERAPY EFFECT; THERMOSTABILITY;

EID: 84922723266     PISSN: 19475764     EISSN: 19475772     Source Type: Journal    
DOI: 10.1615/PlasmaMed.2015012629     Document Type: Article

References (54)

1. Deininger P. Genetic instability in cancer: caretaker and gatekeeper genes. Ochsner J. 1999;1(4):206-9.
2. Elmore S. Apoptosis: a review of programmed cell death. Toxic Pathol. 2007;35(4):495-516.
3. G. F, G Friedman, A Gutsol, AB Shekhter, VN Vasilets, A Fridman. Applied Plasma Medicine. Plasma Process Polym. 2008;5(6):503-33.
4. Kong MG, G Kroesen, G Morfill, T Nosenko, T Shimizu, DJ van, et al. Plasma medicine: an introductory review. New J Phys. 2009;11(11):115012.
5. Lee HW, GY Park, YS Seo, YH Im, SB Shim, HJ Lee. Modelling of atmospheric pressure plasmas for biomedical applications. J Phys D: Appl Phys. 2011;44(5):053001.
6. Park GY, SJ Park, MY Choi, IG Koo, JH Byun, JW Hong, et al. Atmospheric-pressure plasma sources for biomedical applications. Plasma Sources Sci T. 2012;21(4).
7. Kim CH, S Kwon, JH Bahn, K Lee, SI Jun, PD Rack, et al. Effects of atmospheric nonthermal plasma on invasion of colorectal cancer cells. Appl Phys Lett. 2010;96(24):243701.
8. Volotskova O, TS Hawley, MA Stepp, M Keidar. Targeting the cancer cell cycle by cold atmospheric plasma. Scientific Rep. 2012;2:636.
9. Gweon MK, DB Kim, D. Kim, H. Kim, H. Jung, J. H. Shin, and W. Choe. Differential responses of human liver cancer and normal cells to atmospheric pressure plasma. Appl Phys Letts. 2011;99:063701-1-3.
10. Ma Y, CS Ha, SW Hwang, HJ Lee, GC Kim, KW Lee, et al. Non-thermal atmospheric pressure plasma preferentially induces apoptosis in p53-mutated cancer cells by activating ROS stress-response pathways. PloS One. 2014;9(4):e91947.
11. Ishaq M, S Kumar, H Varinli, ZJ Han, AE Rider, MD Evans, et al. Atmospheric gas plasma-induced ROS production activates TNF-ASK1 pathway for the induction of melanoma cancer cell apoptosis. Molec Biol Cell. 2014;25(9):1523-31.
12. Panngom K, KY Baik, MK Nam, JH Han, H Rhim, EH Choi. Preferential killing of human lung cancer cell lines with mitochondrial dysfunction by nonthermal dielectric barrier discharge plasma. Cell Death Dis. 2013;4:e642.
13. Brulle L, M Vandamme, D Ries, E Martel, E Robert, S Lerondel, et al. Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model. PloS One. 2012;7(12):e52653.
14. Vandamme M, E Robert, S Lerondel, V Sarron, D Ries, S Dozias, et al. ROS implication in a new antitumor strategy based on non-thermal plasma. Int J Cancer. 2012;130(9):2185-94.
15. Tanaka H, M Mizuno, K Ishikawa, K Nakamura, H Kajiyama, H Kano, et al. Plasma-activated medium selectively kills glioblastoma brain tumor cells by down-regulating a survival signaling molecule, AKT kinase. 2011;1(3-4):265-77.
16. Utsumi F, H Kajiyama, K Nakamura, H Tanaka, M Mizuno, K Ishikawa, et al. Effect of indirect nonequilibrium atmospheric pressure plasma on anti-proliferative activity against chronic chemo-resistant ovarian cancer cells in vitro and in vivo. PloS One. 2013;8(12):e81576.
17. Tsukagoshi H, W Busch, PN Benfey. Transcriptional regulation of ROS controls transition from proliferation to differentiation in the root. Cell. 2010;143(4):606-16.
18. Wang X, JZ Liu, JX Hu, H Wu, YL Li, HL Chen, et al. ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation. Free Radic Biol Med. 2011;51(2):539-51.
19. Vigneron A, KH Vousden. p53, ROS and senescence in the control of aging. Aging (Albany NY). 2010;2(8):471-4.
20. Simon HU, A Haj-Yehia, F Levi-Schaffer. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000;5(5):415-8.
21. Guzik TJ, NE West, R Pillai, DP Taggart, KM Channon. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension. 2002;39(6):1088-94.
22. Kalghatgi S, CM Kelly, E Cerchar, B Torabi, O Alekseev, A Fridman, et al. Effects of non-thermal plasma on mammalian cells. PloS One. 2011;6(1):e16270.
23. Kang SU, JH Cho, JW Chang, YS Shin, KI Kim, JK Park, et al. Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species. Cell Death Dis. 2014;5:e1056.
24. Mishra OP, AB Zubrow, QM Ashraf. Nitric oxide-mediated activation of extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of newborn piglets. Neuroscience. 2004;123(1):179-86.
25. Endo S, T Launey. Nitric oxide activates extracellular signal-regulated kinase 1/2 and enhances declustering of ionotropic glutamate receptor subunit 2/3 in rat cerebellar Purkinje cells. Neurosci Lett. 2003;350(2):122-6.
26. Giustarini D, R Rossi, A Milzani, I Dalle-Donne. Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol. 2008;440:361-80.
27. Amundson SA, TG Myers, AJ Fornace, Jr. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene. 1998;17(25):3287-99.
28. Fridman JS, SW Lowe. Control of apoptosis by p53. Oncogene. 2003;22(56):9030-40.
29. Hussain SP, P Amstad, P He, A Robles, S Lupold, I Kaneko, et al. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 2004;64(7):2350-6.
30. Yoon KA, Y Nakamura, H Arakawa. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet. 2004;49(3):134-40.
31. Muller PA, KH Vousden. p53 mutations in cancer. Nature cell biology. 2013;15(1):2-8.
32. Paull TT, EP Rogakou, V Yamazaki, CU Kirchgessner, M Gellert, WM Bonner. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000;10(15):886-95.
33. Stiewe T, BM Putzer. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nature Genetics. 2000;26(4):464-9.
34. Yan FZ, SS. Zhao, XP. Lu, Senior Member, IEEE, GY. He, ZL. Xiong, Q. Xiong, QQ. Zhao, PY. Deng, JG. Huang, and GX. Yang. On the mechanism of plasma inducing cell apoptosis. IEEE Trans Plasma Sci. 2010;38:2451-7.
35. Jang ER, M Ryu, JE Park, JH Kim, JS Lee, K Song. A new isoquinolinium derivative, Cadein1, preferentially induces apoptosis in p53-defective cancer cells with functional mismatch repair via a p38-dependent pathway. J Biol Chem. 2010;285(5):2986-95.
36. Cardaci S, G Filomeni, G Rotilio, MR Ciriolo. Reactive oxygen species mediate p53 activation and apoptosis induced by sodium nitroprusside in SH-SY5Y cells. Molecular pharmacology. 2008;74(5):1234-45.
37. Achanta G, P Huang. Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res. 2004;64(17):6233-9.
38. Moreno CS, L Matyunina, EB Dickerson, N Schubert, NJ Bowen, S Logani, et al. Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas. PloS One. 2007;2(5):e441.
39. Trachootham D, Y Zhou, H Zhang, Y Demizu, Z Chen, H Pelicano, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 2006;10(3):241-52.
40. Vafa O, M Wade, S Kern, M Beeche, TK Pandita, GM Hampton, et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002;9(5):1031-44.
41. Sablina AA, AV Budanov, GV Ilyinskaya, LS Agapova, JE Kravchenko, PM Chumakov. The antioxidant function of the p53 tumor suppressor. Nat Med. 2005;11(12):1306-13.
42. Trachootham D, J Alexandre, P Huang. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579-91.
43. Pelicano H, D Carney, P Huang. ROS stress in cancer cells and therapeutic implications. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. 2004;7(2):97-110.
44. Raj L, T Ide, AU Gurkar, M Foley, M Schenone, X Li, et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature. 2011;475(7355):231-4.
45. Lee HR, JM Cho, DH Shin, CS Yong, HG Choi, N Wakabayashi, et al. Adaptive response to GSH depletion and resistance to L-buthionine-(S,R)-sulfoximine: involvement of Nrf2 activation. Mol Cell Biochem. 2008;318(1-2):23-31.
46. Lodish H, Berk A, Kaiser CA, Krieger M, Bretscher A, Ploegh H, Amon A, Scott MP. Molecular cell biology. New York: W.H. Freeman; 2013.
47. Huang J, H Li, W Chen, G-H Lv, X-Q Wang, G-P Zhang, et al. Dielectric barrier discharge plasma in Ar/O2 promoting apoptosis behavior in A549 cancer cells. Appl Physics Letts. 2011;99(25):3701.
48. Yan X, Z Xiong, F Zou, S Zhao, X Lu, G Yang, et al. Plasma-induced death of HepG2 cancer cells: intracellular effects of reactive species. Plasma Proc Polymers. 2012;9(1):59-66.
49. Lu X, F Zou, editors. On the mechanism of plasma inducing cell apoptosis. Plasma Science (ICOPS), 2011 Abstracts IEEE International Conference on 26-30 June 2011.
50. Ahn HJ, KI Kim, G Kim, E Moon, SS Yang, JS Lee. Atmospheric-pressure plasma jet induces apoptosis involving mitochondria via generation of free radicals. PloS One. 2011;6(11):e28154.
51. Sensenig R, S Kalghatgi, E Cerchar, G Fridman, A Shereshevsky, B Torabi, et al. Non-thermal plasma induces apoptosis in melanoma cells via production of intracellular reactive oxygen species. Ann Biomed Engin. 2011;39(2):674-87.
52. Kim CH, JH Bahn, SH Lee, GY Kim, SI Jun, K Lee, et al. Induction of cell growth arrest by atmospheric non-thermal plasma in colorectal cancer cells. J Biotechnol. 2010;150(4):530-8.
53. Kim GJ, W Kim, KT Kim, JK Lee. DNA damage and mitochondria dysfunction in cell apoptosis induced by nonthermal air plasma. Appl Physics Letts. 2010;96(2):1502-1.
54. Chang JW, SU Kang, YS Shin, KI Kim, SJ Seo, SS Yang, et al. Non-thermal atmospheric pressure plasma induces apoptosis in oral cavity squamous cell carcinoma: involvement of DNA-damage-triggering sub-G1 arrest via the ATM/p53 pathway. Arch Biochem Biophys. 2014;545(0):133-40.